Nucletron Kuske Template Reduces Breast Brachytherapy Treatment Time
This article was originally published in The Gray Sheet
Executive Summary
Nucletron will use a recently released ten-year study of its Kuske Breast Templateto promote its interstitial accelerated partial breast irradiation (APBI) system
You may also be interested in...
Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry
Cytyc likely will divest Proxima Therapeutics' GliaSite brain tumor radiation therapy system after acquiring the company for its MammoSite breast cancer system under a $160 mil. deal Feb. 9
Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry
Cytyc likely will divest Proxima Therapeutics' GliaSite brain tumor radiation therapy system after acquiring the company for its MammoSite breast cancer system under a $160 mil. deal Feb. 9
Proxima MammoSite RTS For Early-Stage Breast Cancer To Launch By May 17
Proxima Therapeutics will emphasize its single-catheter MammoSite radiation therapy system's ease of use over multi-catheter competitor devices in treating early-stage breast cancer